BioCentury | May 9, 2011
Company News

BioLink Life Sciences, InVasc deal

...BioLink granted InVasc exclusive, worldwide rights to a patent related to a salt of an alpha...
...to a salt of an alpha lipoic acid derivative. The patent covers potential variations of Invasc's...
...lipoic acid in combination with losartan, an angiotensin II type 1 (AT1) receptor (AGTR1) antagonist. InVasc...
BioCentury | Jul 19, 2010
Company News

InVasc board of directors update

InVasc Therapeutics Inc. , Tucker, Ga. Business: Cardiovascular, Renal, Endocrine Appointed: Daniele Cardoso managing director at Trois I; Larry Dillaha, formerly EVP and CMO of Sciele Pharma Inc. ; CEO William Johnston; and COO Bill Schaeffer...
BioCentury | Jul 19, 2010
Financial News

InVasc completes venture financing

InVasc Therapeutics Inc. , Tucker, Ga. Business: Cardiovascular, Renal, Endocrine Date completed: 7/9/10 Type: Venture financing Raised: $3.2 million Investors: Trois I Investments Industriels Internationaux S.A.; and other investors WIR Staff Cardiovascular Renal...
BioCentury | Jun 1, 2009
Company News

InVasc management update

InVasc Therapeutics Inc. , Tucker, Ga. Business: Cardiovascular Hired: William Johnston as CEO and a director, formerly president and CEO of Inhibitex Inc. ; he replaces Bobby Khan, who remains clinical advisor and a director; William...
Items per page:
1 - 4 of 4
BioCentury | May 9, 2011
Company News

BioLink Life Sciences, InVasc deal

...BioLink granted InVasc exclusive, worldwide rights to a patent related to a salt of an alpha...
...to a salt of an alpha lipoic acid derivative. The patent covers potential variations of Invasc's...
...lipoic acid in combination with losartan, an angiotensin II type 1 (AT1) receptor (AGTR1) antagonist. InVasc...
BioCentury | Jul 19, 2010
Company News

InVasc board of directors update

InVasc Therapeutics Inc. , Tucker, Ga. Business: Cardiovascular, Renal, Endocrine Appointed: Daniele Cardoso managing director at Trois I; Larry Dillaha, formerly EVP and CMO of Sciele Pharma Inc. ; CEO William Johnston; and COO Bill Schaeffer...
BioCentury | Jul 19, 2010
Financial News

InVasc completes venture financing

InVasc Therapeutics Inc. , Tucker, Ga. Business: Cardiovascular, Renal, Endocrine Date completed: 7/9/10 Type: Venture financing Raised: $3.2 million Investors: Trois I Investments Industriels Internationaux S.A.; and other investors WIR Staff Cardiovascular Renal...
BioCentury | Jun 1, 2009
Company News

InVasc management update

InVasc Therapeutics Inc. , Tucker, Ga. Business: Cardiovascular Hired: William Johnston as CEO and a director, formerly president and CEO of Inhibitex Inc. ; he replaces Bobby Khan, who remains clinical advisor and a director; William...
Items per page:
1 - 4 of 4